You just read:

Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount

News provided by

Valeant Pharmaceuticals International, Inc.

Dec 04, 2017, 16:15 EST